Why Is Puma Biotechnology ($PBYI) Stock Down -19.75% Today?
PBYI shares plunged roughly 19.75% to $7.84, extending a selloff that began after third-quarter results were released.
The primary catalyst was a revenue miss and a softer-than-expected U.S. demand picture for its lead drug NERLYNX.
📚 More from Billy’s World
Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y •
YouTube: @BankingWithBilly